Prelude Capital Management’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.56M Buy
108,608
+85,756
+375% +$1.42M 0.12% 208
2025
Q4
$403K Buy
22,852
+12,792
+127% +$212K 0.03% 630
2025
Q3
$158K Buy
+10,060
New +$141K 0.01% 994
2025
Q1
Sell
-11,080
Closed -$152K 1482
2024
Q4
$152K Sell
11,080
-19,950
-64% -$289K 0.01% 1047
2024
Q3
$518K Buy
31,030
+10,685
+53% +$156K 0.03% 615
2024
Q2
$241K Sell
20,345
-2,511
-11% -$28.7K 0.02% 901
2024
Q1
$275K Buy
+22,856
New +$340K 0.01% 941
2023
Q1
Sell
-47,662
Closed -$397K 1439
2022
Q4
$397K Buy
+47,662
New +$356K 0.02% 666
2022
Q1
Sell
-39,654
Closed -$934K 2176
2021
Q4
$934K Sell
39,654
-47,729
-55% -$1.14M 0.02% 651
2021
Q3
$2.29M Buy
87,383
+1,433
+2% +$34.7K 0.06% 263
2021
Q2
$2.08M Sell
85,950
-5,560
-6% -$137K 0.06% 286
2021
Q1
$2.28M Buy
+91,510
New +$2.42M 0.06% 298

Other funds holding SHC

Prelude Capital Management's SHC Position: Q1 2026 in Review

Prelude Capital Management increased its Sotera Health (SHC) stake by 375% in Q1 2026, buying an estimated $1.42M and bringing the position to 108,608 shares worth $1.56M. The position accounts for 0.12% of the portfolio, ranked #208.

Prelude Capital Management first reported a position in SHC in Q1 2021 and has held it in 12 quarters since. The position peaked at $2.29M in Q3 2021. 296 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • Prelude Capital Management held 108,608 shares of Sotera Health worth $1.56M as of Q1 2026.
  • Prelude Capital Management bought 85,756 Sotera Health shares in Q1 2026, an estimated $1.42M.
  • Sotera Health made up 0.12% of Prelude Capital Management's portfolio in Q1 2026, its #208 holding.
  • Prelude Capital Management first reported a position in Sotera Health in Q1 2021 and has held it in 12 quarters since.
  • Prelude Capital Management's Sotera Health position peaked at $2.29M in Q3 2021.
  • 296 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.